Industry: Chemical & Material
Published Date: 2026-03-09
Pages: 78 Pages
Report ld: 6051698
Request Sample
Customized Report
The global Neohesperidoside market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Neohesperidoside is a bioactive compound extracted from natural plants, primarily sourced from the peels of citrus fruits. It possesses various biological activities, including antioxidant, anti-inflammatory, and immune-modulating properties. In the pharmaceutical, food, and cosmetics industries, neohesperidoside has garnered significant attention due to its natural origin and wide-ranging health benefits. As a functional ingredient, it is widely used in health supplements, functional foods, and skincare products to meet the growing consumer demand for natural, healthy, and eco-friendly products. With the increasing global market for natural plant extracts, neohesperidoside holds great market potential and a promising future for research and application.
Market Development Opportunities & Main Driving Factors
The market development opportunities for neohesperidoside are primarily driven by the growing consumer demand for natural and healthy products. As awareness of health issues continues to rise, the application of natural plant extracts in the pharmaceutical, food, and cosmetics industries is expanding. Neohesperidoside, with its multiple bioactive properties, can meet the consumer demand for safe and healthy products. Additionally, the increasing global demand for functional foods and health supplements has propelled the use of neohesperidoside in these areas. Its antioxidant and anti-inflammatory properties make it an ideal health ingredient for developing products that prevent chronic diseases. Meanwhile, the rapid development of emerging markets also provides vast opportunities for the market expansion of neohesperidoside.
Market Challenges, Risks, & Restraints
Despite the promising market outlook for neohesperidoside, it also faces several challenges and risks. Firstly, its extraction process is relatively complex and costly, which may limit its large-scale production and application. Moreover, the market competition is fierce, with numerous similar natural plant extracts available. Neohesperidoside needs to differentiate itself in terms of product quality and functionality. The strictness of regulations and standards is another challenge, as different countries and regions have varying regulatory requirements for natural plant extracts. Companies need to ensure their products comply with relevant regulations to avoid market access barriers. Lastly, consumer awareness and acceptance of natural products vary, and some may question the efficacy and safety of neohesperidoside, necessitating stronger market education and brand building by companies.
Downstream Demand Trends
The downstream demand trends for neohesperidoside are characterized by diversification and high-end application. In the pharmaceutical sector, its antioxidant and anti-inflammatory properties make it a key ingredient for developing new drugs and health supplements. With increasing attention to the prevention of chronic diseases, the application of neohesperidoside in products for cardiovascular diseases, diabetes, and inflammation-related conditions is set to grow. In the food industry, the demand for functional foods drives the use of neohesperidoside in beverages, health supplements, and nutritional additives. Its natural origin and health benefits make it an ideal food ingredient. In the cosmetics field, its antioxidant properties offer broad prospects for anti-aging and skincare products. As consumer demand for natural skincare products rises, the application of neohesperidoside in high-end skincare products is expected to expand.
The global Neohesperidoside market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term
Chapter 2: Quantitative analysis of Neohesperidoside sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region
Chapter 3: Competitive landscape of Neohesperidoside manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans)
Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments
Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets
Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment)
Chapter 7: Key manufacturer profiles –company overview, Neohesperidoside product descriptions and specifications, revenue, gross margins, and recent developments
Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors
Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces
Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies
Chapter 11: Key findings, main takeaways, and overall conclusions of the report.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Neohesperidoside value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Neohesperidoside Product Scope
1.2 Neohesperidoside by Type
1.2.1 Global Neohesperidoside Sales by Type (2021, 2025 & 2032)
1.2.2 Food Grade
1.2.3 Industrial Grade
1.2.4 Pharmacy Grade
1.3 Neohesperidoside by Application
1.3.1 Global Neohesperidoside Sales Comparison by Application (2021, 2025 & 2032)
1.3.2 Food
1.3.3 Cosmetics
1.3.4 Medicine
1.4 Global Neohesperidoside Market Estimates and Forecasts (2021-2032)
1.4.1 Global Neohesperidoside Market Size (Value) and Growth Rate (2021-2032)
1.4.2 Global Neohesperidoside Market Size (Volume) and Growth Rate (2021-2032)
1.4.3 Global Neohesperidoside Price Trends (2021-2032)
1.5 Assumptions and Limitations
2 Market Size and Prospects by Region
2.1 Global Neohesperidoside Market Size by Region: 2021 VS 2025 VS 2032
2.2 Global Neohesperidoside Historical Market Scenario by Region (2021-2026)
2.2.1 Global Neohesperidoside Sales Market Share by Region (2021-2026)
2.2.2 Global Neohesperidoside Revenue Market Share by Region (2021-2026)
2.3 Global Neohesperidoside Market Estimates and Forecasts by Region (2027-2032)
2.3.1 Global Neohesperidoside Sales Estimates and Forecasts by Region (2027-2032)
2.3.2 Global Neohesperidoside Revenue Forecast by Region (2027-2032)
2.4 Major Regions and Emerging Market Analysis
2.4.1 North America Neohesperidoside Market Size and Prospects (2021-2032)
2.4.2 Europe Neohesperidoside Market Size and Prospects (2021-2032)
2.4.3 China Neohesperidoside Market Size and Prospects (2021-2032)
2.4.4 Japan Neohesperidoside Market Size and Prospects (2021-2032)
2.4.5 India Neohesperidoside Market Size and Prospects (2021-2032)
2.4.6 Southeast Asia Neohesperidoside Market Size and Prospects (2021-2032)
3 Global Market Size by Type
3.1 Global Neohesperidoside Historical Market Review by Type (2021-2026)
3.1.1 Global Neohesperidoside Sales by Type (2021-2026)
3.1.2 Global Neohesperidoside Revenue by Type (2021-2026)
3.1.3 Global Neohesperidoside Average Price by Type (2021-2026)
3.2 Global Neohesperidoside Market Estimates and Forecasts by Type (2027-2032)
3.2.1 Global Neohesperidoside Sales Forecast by Type (2027-2032)
3.2.2 Global Neohesperidoside Revenue Forecast by Type (2027-2032)
3.2.3 Global Neohesperidoside Price Forecast by Type (2027-2032)
3.3 Representative Players for Different Types of Neohesperidoside
4 Global Market Size by Application
4.1 Global Neohesperidoside Historical Market Review by Application (2021-2026)
4.1.1 Global Neohesperidoside Sales by Application (2021-2026)
4.1.2 Global Neohesperidoside Revenue by Application (2021-2026)
4.1.3 Global Neohesperidoside Average Price by Application (2021-2026)
4.2 Global Neohesperidoside Market Estimates and Forecasts by Application (2027-2032)
4.2.1 Global Neohesperidoside Sales Forecast by Application (2027-2032)
4.2.2 Global Neohesperidoside Revenue Forecast by Application (2027-2032)
4.2.3 Global Neohesperidoside Price Forecast by Application (2027-2032)
4.3 New Sources of Growth in Neohesperidoside Applications
5 Competition Landscape by Players
5.1 Global Neohesperidoside Sales by Player (2021-2026)
5.2 Global Top Neohesperidoside Players by Revenue (2021-2026)
5.3 Global Neohesperidoside Market Share by Company Type (Tier 1, Tier 2, and Tier 3), based on Neohesperidoside revenue as of 2025
5.4 Global Neohesperidoside Average Price by Company (2021-2026)
5.5 Global Key Manufacturers of Neohesperidoside, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Neohesperidoside, Product Type & Application
5.7 Global Key Manufacturers of Neohesperidoside, Date of Entry into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Regional Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Neohesperidoside Sales by Company
6.1.1.1 North America Neohesperidoside Sales by Company (2021-2026)
6.1.1.2 North America Neohesperidoside Revenue by Company (2021-2026)
6.1.2 North America Neohesperidoside Sales Breakdown by Type (2021-2026)
6.1.3 North America Neohesperidoside Sales Breakdown by Application (2021-2026)
6.1.4 North America Neohesperidoside Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Neohesperidoside Sales by Company
6.2.1.1 Europe Neohesperidoside Sales by Company (2021-2026)
6.2.1.2 Europe Neohesperidoside Revenue by Company (2021-2026)
6.2.2 Europe Neohesperidoside Sales Breakdown by Type (2021-2026)
6.2.3 Europe Neohesperidoside Sales Breakdown by Application (2021-2026)
6.2.4 Europe Neohesperidoside Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Neohesperidoside Sales by Company
6.3.1.1 China Neohesperidoside Sales by Company (2021-2026)
6.3.1.2 China Neohesperidoside Revenue by Company (2021-2026)
6.3.2 China Neohesperidoside Sales Breakdown by Type (2021-2026)
6.3.3 China Neohesperidoside Sales Breakdown by Application (2021-2026)
6.3.4 China Neohesperidoside Major Customers
6.3.5 China Market Trends and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Neohesperidoside Sales by Company
6.4.1.1 Japan Neohesperidoside Sales by Company (2021-2026)
6.4.1.2 Japan Neohesperidoside Revenue by Company (2021-2026)
6.4.2 Japan Neohesperidoside Sales Breakdown by Type (2021-2026)
6.4.3 Japan Neohesperidoside Sales Breakdown by Application (2021-2026)
6.4.4 Japan Neohesperidoside Major Customers
6.4.5 Japan Market Trends and Opportunities
6.5 India Market: Players, Segments, Downstream and Major Customers
6.5.1 India Neohesperidoside Sales by Company
6.5.1.1 India Neohesperidoside Sales by Company (2021-2026)
6.5.1.2 India Neohesperidoside Revenue by Company (2021-2026)
6.5.2 India Neohesperidoside Sales Breakdown by Type (2021-2026)
6.5.3 India Neohesperidoside Sales Breakdown by Application (2021-2026)
6.5.4 India Neohesperidoside Major Customers
6.5.5 India Market Trends and Opportunities
6.6 Southeast Asia Market: Players, Segments, Downstream and Major Customers
6.6.1 Southeast Asia Neohesperidoside Sales by Company
6.6.1.1 Southeast Asia Neohesperidoside Sales by Company (2021-2026)
6.6.1.2 Southeast Asia Neohesperidoside Revenue by Company (2021-2026)
6.6.2 Southeast Asia Neohesperidoside Sales Breakdown by Type (2021-2026)
6.6.3 Southeast Asia Neohesperidoside Sales Breakdown by Application (2021-2026)
6.6.4 Southeast Asia Neohesperidoside Major Customers
6.6.5 Southeast Asia Market Trends and Opportunities
7 Company Profiles and Key Figures
7.1 Biospringer
7.1.1 Biospringer Company Information
7.1.2 Biospringer Business Overview
7.1.3 Biospringer Neohesperidoside Sales, Revenue and Gross Margin (2021-2026)
7.1.4 Biospringer Neohesperidoside Products Offered
7.1.5 Biospringer Recent Development
7.2 BASF SE
7.2.1 BASF SE Company Information
7.2.2 BASF SE Business Overview
7.2.3 BASF SE Neohesperidoside Sales, Revenue and Gross Margin (2021-2026)
7.2.4 BASF SE Neohesperidoside Products Offered
7.2.5 BASF SE Recent Development
7.3 Cargill
7.3.1 Cargill Company Information
7.3.2 Cargill Business Overview
7.3.3 Cargill Neohesperidoside Sales, Revenue and Gross Margin (2021-2026)
7.3.4 Cargill Neohesperidoside Products Offered
7.3.5 Cargill Recent Development
7.4 Chr.Hansen Holding A/S
7.4.1 Chr.Hansen Holding A/S Company Information
7.4.2 Chr.Hansen Holding A/S Business Overview
7.4.3 Chr.Hansen Holding A/S Neohesperidoside Sales, Revenue and Gross Margin (2021-2026)
7.4.4 Chr.Hansen Holding A/S Neohesperidoside Products Offered
7.4.5 Chr.Hansen Holding A/S Recent Development
7.5 Corbion NV
7.5.1 Corbion NV Company Information
7.5.2 Corbion NV Business Overview
7.5.3 Corbion NV Neohesperidoside Sales, Revenue and Gross Margin (2021-2026)
7.5.4 Corbion NV Neohesperidoside Products Offered
7.5.5 Corbion NV Recent Development
7.6 CP Kelco
7.6.1 CP Kelco Company Information
7.6.2 CP Kelco Business Overview
7.6.3 CP Kelco Neohesperidoside Sales, Revenue and Gross Margin (2021-2026)
7.6.4 CP Kelco Neohesperidoside Products Offered
7.6.5 CP Kelco Recent Development
7.7 DowDuPont
7.7.1 DowDuPont Company Information
7.7.2 DowDuPont Business Overview
7.7.3 DowDuPont Neohesperidoside Sales, Revenue and Gross Margin (2021-2026)
7.7.4 DowDuPont Neohesperidoside Products Offered
7.7.5 DowDuPont Recent Development
7.8 Edlong Dairy Technologies
7.8.1 Edlong Dairy Technologies Company Information
7.8.2 Edlong Dairy Technologies Business Overview
7.8.3 Edlong Dairy Technologies Neohesperidoside Sales, Revenue and Gross Margin (2021-2026)
7.8.4 Edlong Dairy Technologies Neohesperidoside Products Offered
7.8.5 Edlong Dairy Technologies Recent Development
7.9 Firmenich SA
7.9.1 Firmenich SA Company Information
7.9.2 Firmenich SA Business Overview
7.9.3 Firmenich SA Neohesperidoside Sales, Revenue and Gross Margin (2021-2026)
7.9.4 Firmenich SA Neohesperidoside Products Offered
7.9.5 Firmenich SA Recent Development
7.10 FMC Health and Nutrition
7.10.1 FMC Health and Nutrition Company Information
7.10.2 FMC Health and Nutrition Business Overview
7.10.3 FMC Health and Nutrition Neohesperidoside Sales, Revenue and Gross Margin (2021-2026)
7.10.4 FMC Health and Nutrition Neohesperidoside Products Offered
7.10.5 FMC Health and Nutrition Recent Development
8 Neohesperidoside Manufacturing Cost Analysis
8.1 Neohesperidoside Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Neohesperidoside
8.4 Neohesperidoside Industrial Chain Analysis
9 Marketing Channels, Distributors and Customers
9.1 Marketing Channels
9.2 Neohesperidoside Distributors List
9.3 Neohesperidoside Customers
10 Neohesperidoside Market Dynamics
10.1 Neohesperidoside Industry Trends
10.2 Neohesperidoside Market Drivers
10.3 Neohesperidoside Market Challenges
10.4 Neohesperidoside Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Neohesperidoside market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-09
Pages: 133
USD 4900.00
(Single User License)
The global market for Neohesperidoside was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-03-05
Pages: 108
USD 3950.00
(Single User License)
The global Neohesperidoside market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-03-05
Pages: 129
USD 2900.00
(Single User License)
The global Neohesperidoside market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-26
Pages: 145
USD 4900.00
(Single User License)
The global market for Neohesperidoside was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-14
Pages: 102
USD 3950.00
(Single User License)
The global Neohesperidoside market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-14
Pages: 80
USD 4250.00
(Single User License)
The global market for Neohesperidoside was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-08-14
Pages: 92
USD 2900.00
(Single User License)
The global market for Neohesperidoside was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 97
USD 3950.00
(Single User License)
The global market for Neohesperidoside was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-16
Pages: 126
USD 3950.00
(Single User License)
The global Neohesperidoside market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-04
Pages: 95
USD 2900.00
(Single User License)
The global Neohesperidoside market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-09
Pages: 133
The global market for Neohesperidoside was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-03-05
Pages: 108
The global Neohesperidoside market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-03-05
Pages: 129
The global Neohesperidoside market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-26
Pages: 145
The global market for Neohesperidoside was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-14
Pages: 102
The global Neohesperidoside market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-14
Pages: 80
The global market for Neohesperidoside was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-08-14
Pages: 92
The global market for Neohesperidoside was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 97
The global market for Neohesperidoside was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-16
Pages: 126
The global Neohesperidoside market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-04
Pages: 95
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now